Benjamin Thierry

University of South Australia

Papers

2

Total Citations

11

H-Index

2

About

Benjamin Thierry is a pioneering biomedical researcher whose work sits at the intersection of surgical oncology, nanotechnology, and advanced imaging. His primary research focuses on developing novel, multi-modality approaches for sentinel lymph node biopsy (SLNB), aiming to improve the precision and reduce the invasiveness of cancer staging procedures. Thierry’s major contributions include the preclinical validation of mannose-labelled magnetic nanoparticles combined with indocyanine green for sentinel node localization in gastric cancer—a technique that promises to enhance the accuracy of D2 lymphadenectomy while potentially reducing complications. He has also demonstrated the preclinical feasibility of robot-assisted SLNB in the head and neck, integrating magnetic and fluorescence guidance to enable access to multiple neck levels through a single incision. Though his most-cited works are recent (2022–2023), they have already garnered 7 and 4 citations respectively, signaling growing impact in the field. Thierry’s innovative fusion of magnetic and optical tracers with robotic platforms positions him at the forefront of next-generation, minimally invasive cancer surgery, with clear translational potential for improving patient outcomes.

Research Focus

Key Achievements

2
H-Index
2
Papers
11
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Preclinical evaluation of sentinel node localization in the stomach via mannose-labelled magnetic nanoparticles and indocyanine green
7 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: University of South Australia

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago